Published in AIDS on April 23, 2007
Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis (2010) 4.56
Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis (2010) 2.86
Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome. Am J Respir Crit Care Med (2008) 1.76
Immune reconstitution inflammatory syndrome in HIV-infected patients. HIV AIDS (Auckl) (2015) 1.61
Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur Respir J (2010) 1.57
Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy. Expert Rev Anti Infect Ther (2011) 1.20
Immunopathogenesis of immune reconstitution disease in HIV patients responding to antiretroviral therapy. Curr Opin HIV AIDS (2008) 1.00
HIV-1 and the immune response to TB. Future Virol (2013) 0.97
LPS-binding protein and IL-6 mark paradoxical tuberculosis immune reconstitution inflammatory syndrome in HIV patients. PLoS One (2013) 0.89
Lower Pre-Treatment T Cell Activation in Early- and Late-Onset Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome. PLoS One (2015) 0.79
Auxiliary diagnostic value of monocyte chemoattractant protein-1 of whole blood in active tuberculosis. Int J Clin Exp Med (2015) 0.75
Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol (2002) 2.83
Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res (2006) 2.15
Patterned genital injury in cases of rape--a case-control study. J Forensic Leg Med (2013) 2.00
Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy : pathogenesis, clinical manifestations and management. Drugs (2008) 1.95
Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. J Clin Microbiol (2004) 1.81
CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect (2007) 1.55
Hormone replacement therapy increases the risk of cranial meningioma. Eur J Cancer (2013) 1.47
Risk for tuberculosis among children. Emerg Infect Dis (2006) 1.40
Prevalence of substance abuse in pregnancy among Danish women. Acta Obstet Gynecol Scand (2014) 1.40
Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS One (2008) 1.39
Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-gamma whole-blood test. Scand J Infect Dis (2007) 1.38
A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis (Edinb) (2011) 1.34
IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay. BMC Res Notes (2009) 1.29
IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions. Expert Rev Mol Diagn (2012) 1.26
The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS One (2009) 1.24
Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. Am J Respir Crit Care Med (2014) 1.22
Point-of-care diagnosis of tuberculosis: past, present and future. Respirology (2013) 1.20
Beyond the IFN-γ horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis. Eur Respir J (2013) 1.19
Correlates for disease progression and prognosis during concurrent HIV/TB infection. Int J Infect Dis (2007) 1.18
Evaluation of Mycobacterium tuberculosis--specific antibody responses in populations with different levels of exposure from Tanzania, Ethiopia, Brazil, and Denmark. Clin Infect Dis (2007) 1.17
Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal. Bone (2003) 1.16
Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection. Inflamm Bowel Dis (2011) 1.09
Perspectives in implementing standardized case definitions for tuberculosis research involving children in a low-income, high-burden setting. J Infect Dis (2012) 1.08
Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases. J Rheumatol (2009) 1.07
QuantiFERON®-TB gold in-tube performance for diagnosing active tuberculosis in children and adults in a high burden setting. PLoS One (2012) 1.03
Postmenopausal endometriosis. Acta Obstet Gynecol Scand (2007) 1.03
Changes in bone density and turnover after alendronate or estrogen withdrawal. Menopause (2004) 1.01
Identification of Rv0222 from RD4 as a novel serodiagnostic target for tuberculosis. Tuberculosis (Edinb) (2008) 1.00
Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007. BMC Pulm Med (2011) 0.97
A simple method to quantitate IP-10 in dried blood and plasma spots. PLoS One (2012) 0.95
Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper. Eur Respir J (2013) 0.93
Incubation of whole blood at 39°C augments gamma interferon (IFN-γ)-induced protein 10 and IFN-γ responses to Mycobacterium tuberculosis antigens. Clin Vaccine Immunol (2011) 0.93
Three cases of severely disseminated Staphylococcus aureus infection in patients treated with tocilizumab. BMJ Case Rep (2013) 0.91
Prevention of postmenopausal bone loss: six-year results from the Early Postmenopausal Intervention Cohort Study. J Clin Endocrinol Metab (2004) 0.90
Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study. Scand J Infect Dis (2011) 0.90
Primary health care staff's perceptions of childhood tuberculosis: a qualitative study from Tanzania. BMC Health Serv Res (2012) 0.89
Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls. Scand J Infect Dis (2014) 0.88
Biomarkers of latent TB infection. Expert Rev Respir Med (2009) 0.88
Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection. Pediatr Infect Dis J (2008) 0.88
Visceral fat is more important than peripheral fat for endometrial thickness and bone mass in healthy postmenopausal women. Am J Obstet Gynecol (2003) 0.87
Tuberculosis burden in an urban population: a cross sectional tuberculosis survey from Guinea Bissau. BMC Infect Dis (2010) 0.86
Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark. Clin Endocrinol (Oxf) (2010) 0.85
Negative effect of smoking on the performance of the QuantiFERON TB gold in tube test. BMC Infect Dis (2012) 0.84
Smoking is associated with increased adrenal responsiveness, decreased prolactin levels and a more adverse lipid profile in 650 white patients with polycystic ovary syndrome. Gynecol Endocrinol (2011) 0.84
Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome. J Clin Endocrinol Metab (2014) 0.84
Hormone replacement therapy and risk of glioma: a nationwide nested case-control study. Cancer Epidemiol (2013) 0.83
Hormonal contraceptive use and risk of glioma among younger women: a nationwide case-control study. Br J Clin Pharmacol (2015) 0.82
Specific and unspecific gynecological alarm symptoms--prevalence estimates in different age groups: a population-based study. Acta Obstet Gynecol Scand (2014) 0.82
The prevalence of endometrial hyperplasia and endometrial cancer in women with polycystic ovary syndrome or hyperandrogenism. Acta Obstet Gynecol Scand (2012) 0.82
Pulsed estrogen therapy improves postmenopausal quality of life: a 2-year placebo-controlled study. Maturitas (2006) 0.82
Challenges of loss to follow-up in tuberculosis research. PLoS One (2012) 0.81
Long-term follow up after uterine artery embolization for symptomatic uterine leiomyomas. Acta Obstet Gynecol Scand (2011) 0.81
Inflammatory markers in the second trimester prior to clinical onset of preeclampsia, intrauterine growth restriction, and spontaneous preterm birth. Inflammation (2013) 0.80
Guidelines for screening, prophylaxis and critical information prior to initiating anti-TNF-alpha treatment. Dan Med J (2012) 0.80
High frequency of congenital thrombophilia in women with pathological pregnancies? Acta Obstet Gynecol Scand (2004) 0.79
Nature, frequency and duration of genital lesions after consensual sexual intercourse--implications for legal proceedings. Forensic Sci Int (2011) 0.79
Getting personal perspectives on individualized treatment duration in multidrug-resistant and extensively drug-resistant tuberculosis. Am J Respir Crit Care Med (2014) 0.79
Evaluation of QuantiFERON microtube, using 0.9 mL blood, for diagnosing tuberculosis infection. Eur Respir J (2012) 0.78
Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes. Acta Obstet Gynecol Scand (2014) 0.78
Evaluation of the filter paper IP-10 tests in school children after exposure to tuberculosis: a prospective cohort study with a 4-year follow-up. BMJ Open (2012) 0.78
QuantiFERON–TB Gold In-Tube test performance in Denmark. Tuberculosis (Edinb) (2014) 0.77
Combined oral contraceptives' influence on weight, body composition, height, and bone mineral density in girls younger than 18 years: a systematic review. Eur J Contracept Reprod Health Care (2012) 0.77
Tumor-associated antigens identified by mRNA expression profiling as tumor rejection epitopes. J Immune Based Ther Vaccines (2003) 0.77
[Comparison of QuantiFERON and tuberculin skin test in possible suspected tuberculosis infection]. Ugeskr Laeger (2009) 0.77
ELISA-based assay for IP-10 detection from filter paper samples. Methods Mol Biol (2014) 0.76
Lymphangioleiomyomatosis in a patient with tuberous sclerosis and dysregulated diabetes mellitus. Acta Derm Venereol (2009) 0.76
Trimegestone in a low-dose, continuous-combined hormone therapy regimen prevents bone loss in osteopenic postmenopausal women. Menopause (2004) 0.75
[Primary cutaneous cryptococcosis in a pigeon breeder]. Ugeskr Laeger (2011) 0.75
[Clostridium difficile ribotype 027 is a challenge]. Ugeskr Laeger (2014) 0.75
[Pericardial tuberculosis is still an important differential diagnosis in Denmark]. Ugeskr Laeger (2013) 0.75
Pulsed estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study. Osteoporos Int (2003) 0.75
[Indicator-based HIV testing]. Ugeskr Laeger (2015) 0.75
[Uterine fibroids]. Ugeskr Laeger (2017) 0.75
[Development of tuberculosis after treatment with the TNF-alpha inhibitor infliximab]. Ugeskr Laeger (2005) 0.75
Motivational interviewing: a part of the weight loss program for overweight and obese women prior to fertility treatment. Gynecol Endocrinol (2013) 0.75
Effects of exercise and group counselling on body composition and VO2max in overweight women with polycystic ovary syndrome. Acta Obstet Gynecol Scand (2013) 0.75
Colposcopic photography of genital injury following sexual intercourse in adults. Forensic Sci Med Pathol (2012) 0.75
Detection of spermatozoa following consensual sexual intercourse. Forensic Sci Int (2012) 0.75